United States News Todas as matérias

Trump used his Davos speech to tout US economic dominance, promote crypto, and revive his push for Greenland.

Bitcoin’s brief surge above $90,000 after Trump’s Davos comments quickly faded as global market volatility intensified.

Prominent crypto voices say banking interests are blocking progress as the CLARITY Act remains stuck in the US Senate.

Elliptic claims Iran’s central bank used stablecoins to quietly build a $500 million sanctions-resistant reserve.

Bitcoin and Ether ETFs recorded major outflows as global macro risks drove institutional caution.

Netflix just crossed 325 million subscribers and beat revenue with $12.1 billion in Q4, yet its stock slid as markets focused elsewhere.

Lexicon Pharmaceuticals (NASDAQ:LXRX) successfully completed an End-of-Phase 2 (EOP2) meeting with the U.S. Food and Drug Administration for its lead pain candidate, pilavapadin.

City Holding Company (NASDAQ:CHCO) capped a historic 2025 with record annual net income of $130.5 million, as the West Virginia-based lender defied industry-wide margin pressures through robust loan growth and stellar efficiency.

Dr. Reddy’s Laboratories (NYSE:RDY) reported fiscal third-quarter revenue that surpassed analyst expectations Wednesday, as explosive growth in emerging markets and a resilient domestic business in India helped offset a steep decline in its North American generic portfolio.

Truist Financial (NYSE:TFC) reported fourth-quarter adjusted earnings that cleared Wall Street hurdles, supported by a significant $10 billion share repurchase authorization and expanding margins.

Greene County Bancorp (NASDAQ:GCBC) reported a surge in profitability, achieving the highest quarterly and six-month earnings in its 137-year history.

Smithfield Foods (NASDAQ:SFD) announced Wednesday that it will acquire iconic hot dog maker Nathan’s Famous (NASDAQ:NATH) in an all-cash transaction valued at $102 per share, or approximately $450 million in enterprise value.

Beneficient (NASDAQ:BENF) shares are in focus Wednesday after a federal court granted final approval to a binding settlement resolving all claims related to the collapse of GWG Holdings against the company and its leadership.

Revelation Biosciences (NASDAQ:REVB) announced it has reached a milestone agreement with the FDA on an "expedient" approval pathway for Gemini, its lead candidate for the treatment of Acute Kidney Injury (AKI).

Lisata Therapeutics (NASDAQ:LSTA) shares soared Wednesday morning after the clinical-stage biotech announced a binding agreement to be acquired by privately held Kuva Labs.

Ionis Pharmaceuticals (NASDAQ:IONS) and Otsuka Pharmaceutical achieved a major regulatory victory Wednesday as the European Commission (EC) granted marketing authorization for DAWNZERA (donidalorsen).

Community Trust Bancorp (NASDAQ:CTBI) delivered a record-shattering 2025, capped by a fourth quarter that saw net income surge to $27.3 million—a 21% increase over the same period last year.

Prologis (NYSE:PLD) signaled a robust outlook for the coming year, projecting a significant step-up in Core FFO as the warehouse giant successfully pivots toward digital infrastructure and renewable energy.

Ally Financial (NYSE:ALLY) shares were volatile Wednesday after the Detroit-based lender posted fourth-quarter adjusted earnings that comfortably cleared Wall Street hurdles, though a slight revenue miss highlighted the ongoing challenges of high funding costs.

MakeMyTrip (NASDAQ:MMYT) reported a surge in adjusted profitability for its fiscal third quarter, as the Gurgaon-based travel leader successfully leveraged its diversified portfolio to navigate a cooling domestic aviation market.

Old National Bancorp (NASDAQ:ONB) shares remained steady Wednesday after the Evansville-based lender posted fourth-quarter adjusted earnings that cleared Wall Street hurdles, capping what leadership described as an "exceptional" year of growth.

The Charles Schwab Corporation (NYSE:SCHW) reported record-breaking fourth-quarter and full-year 2025 results, signaling a definitive end to the "cash sorting" challenges that plagued the brokerage giant following the 2023 regional banking crisis.

Dana Incorporated (NYSE:DAN) on Wednesday reported preliminary 2025 results at the high end of expectations and unveiled a 2026 roadmap centered on margin expansion and aggressive capital returns.

The Travelers Companies (NYSE:TRV) reported a significant jump in fourth-quarter profit, surpassing analyst expectations as the insurance giant benefited from a combination of aggressive premium increases, a relatively quiet period for natural disasters, and soaring investment returns.